Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)
Early Phase 1
- Conditions
- Refractory Overactive Bladder
- Registration Number
- NCT02619721
- Lead Sponsor
- Beijing Pins Medical Co., Ltd
- Brief Summary
Evaluate the long-term clinical effectiveness and safety of the PINS Sacral Neuromodulation to patients with refractory Overactive Bladder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
- Age greater than 16 years OAB and/or OAB symptoms Refractory to standard medical therapy 100ml bladder capacity with normal upper urinary tract Good surgical candidate Able to complete study documentation and return for followup evaluation
Exclusion Criteria
- Neurological conditions Stress urinary incontinence OAB symptoms caused by urinary tract infections
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Changes in voiding frequency from baseline to the voiding frequency evaluvation period 6 month 6 month of stimulation
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of PINS Sacral Neuromodulation in refractory Overactive Bladder?
How does PINS SNS compare to anticholinergic drugs in treating refractory OAB patients?
Are there specific biomarkers that identify candidates for PINS SNS therapy in refractory OAB?
What are the long-term adverse events associated with PINS SNS in refractory OAB patients?
What combination therapies or alternative devices are being explored for refractory Overactive Bladder treatment?
Trial Locations
- Locations (1)
Beijing Hospital
🇨🇳Beijing, Beijing, China
Beijing Hospital🇨🇳Beijing, Beijing, China